Advertisement
Screener

SELLAS Life Sciences Group, Inc. (SLS) ROE

SELLAS Life Sciences Group, Inc. (SLS) ROE

  • 2026-06-30: ROE -23.58%.
  • 2026-03-31: ROE -27.42%.
  • 2025-12-31: ROE -37.90%.
  • 2025-09-30: ROE -56.85%.

Complete source-backed roe history.

Available history
2010-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-30-23.58%
2026-03-31-27.42%
2025-12-31-37.90%
2025-09-30-56.85%
2025-06-30-100.42%
2025-03-31-97.73%
2024-12-31-326.27%
2024-09-30-203.12%
2024-06-30-1182.25%
2024-03-31-369.77%
2023-12-31468.15%
2023-09-301001.44%
2023-06-30-744.99%
2023-03-31-270.74%
2022-12-31-851.39%
2022-09-30-307.84%
2022-06-30-203.81%
2022-03-31-870.56%
2021-12-31-101.73%
2021-09-30-66.96%
2021-06-30-45.50%
2021-03-31-52.25%
2020-12-31-59.93%
2020-09-30-257.42%
2020-06-30-533.68%
2020-03-31-234.41%
2019-12-31-316.63%
2019-09-30-236.87%
2019-06-30-148.44%
2019-03-31-820.75%
2018-12-31-527.55%
2018-09-30-125.33%
2018-06-301099.36%
2018-03-312059.79%
2017-12-31-1147.54%
2017-09-30-99.87%
2017-06-30-89.36%
2017-03-31-21.29%
2016-12-31353.83%
2016-09-30-157.59%
2016-06-30-240.19%
2016-03-31-562.77%
2015-12-31521.13%
2015-09-30-160.96%
2015-06-30-81.69%
2015-03-31-75.50%
2014-12-31-98.78%
2014-09-30-250.01%
2014-06-30-283.51%
2014-03-31-150.35%
2013-12-31-1302.72%
2013-09-30-92.22%
2013-06-30-189.76%
2013-03-31-83.65%
2012-12-31-125.99%
2012-09-30-209.17%
2012-06-30-150.88%
2012-03-31306.54%
2011-12-31-113.54%
2011-09-30-316.44%
2011-06-30-137.54%

Annual ROE

DateROE
2025-12-31-37.90%
2024-12-31-326.27%
2023-12-31468.15%
2022-12-31-851.39%
2021-12-31-101.73%
2020-12-31-59.93%
2019-12-31-316.63%
2018-12-31-527.55%
2017-12-31-1147.54%
2016-12-31353.83%
2015-12-31521.14%
2014-12-31-98.78%
2013-12-31-1302.72%
2012-12-31-125.99%
2011-12-31-113.58%
2010-12-31-493.54%

Similar stocks

Stock NameCountryMarket CapPE Ratio
uniQure N.V. (QURE)$2.416B-4.93
Vera Therapeutics, Inc. (VERA)United States$2.402B-7.67
Harmony Biosciences Holdings, Inc. (HRMY)United States$2.399B11.67
Nurix Therapeutics, Inc. (NRIX)United States$2.457B-5.39
Mineralys Therapeutics, Inc. (MLYS)United States$2.353B-6.82
Viridian Therapeutics, Inc.\DE (VRDN)United States$2.342B-5.38
SUPERNUS PHARMACEUTICALS, INC. (SUPN)United States$2.517B-24.63
Immunome Inc. (IMNM)United States$2.538B-9.45
Disc Medicine, Inc. (IRON)United States$2.553B-11.40
Zai Lab Ltd (ZLAB)$2.241B-113.34